Publication Name	World Journal of Clinical Oncology
Manuscript ID	61988
Country	Spain

Received	2020-12-24 18:04
Peer-Review Started	2020-12-24 18:06
To Make the First Decision
Return for Revision	2021-01-11 03:24
Revised	2021-01-23 19:52
Second Decision	2021-02-25 03:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-03-09 16:51
Articles in Press	2021-03-09 16:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-03-24 15:15
Publish the Manuscript Online	2021-04-20 12:49

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Guidelines
Article Title	GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours
Manuscript Source	Invited Manuscript
All Author List	Mikel Rico, Sonia Flamarique, Cristina Casares, Tamara García, Miriam López, Maribel Martínez, Javier Serrano, Manuel Blanco, Raúl Hernanz, Lourdes de Ingunza-Barón, Francisco José Marcos and Felipe Couñago
Funding Agency and Grant Number
Corresponding Author	Mikel Rico, MD, PhD, Doctor, Department of Radiation Oncology, Complejo Hospitalario de Navarra, C/Irunlarrea 3, Pamplona 31008, Navarra, Spain. mikel.rico.oses@navarra.es
Key Words	Targeted therapies; Thymic epithelial tumors; Radiotherapy; Reirradiation; Guidelines; Chemotherapy
Core Tip	Thymic epithelial tumours (TET) are rare, heterogeneous tumours. The clinical management of these tumours is largely based on studies with a low level of evidence. For this reason, it is especially important to develop guidelines to help guide the optimal approach to managing this disease. The present clinical guidelines review the main recommendations for the diagnosis and classification of TET, providing recommendations for the therapeutic approach based on the tumour stage and pathological anatomy. An important focus of these guidelines is the role of radiotherapy and novel therapies.
Publish Date	2021-04-20 12:49
Citation	Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216
URL	https://www.wjgnet.com/2218-4333/full/v12/i4/195.htm
DOI	https://dx.doi.org/10.5306/wjco.v12.i4.195

Full Article (PDF)	WJCO-12-195.pdf
Full Article (Word)	WJCO-12-195.docx
Manuscript File	61988_Auto_Edited_LM.docx
Answering Reviewers	61988-Answering reviewers.pdf
Audio Core Tip	61988-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	61988-Conflict-of-interest statement.pdf
Copyright License Agreement	61988-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	61988-Language certificate.pdf
Peer-review Report	61988-Peer-review(s).pdf
Scientific Misconduct Check	61988-Bing-Wang JL-1.jpg
Scientific Misconduct Check	61988-Bing-Fan JR-2.png
Scientific Misconduct Check	61988-Scientific misconduct check.pdf
Scientific Editor Work List	61988-Scientific editor work list.pdf